124 related articles for article (PubMed ID: 38869095)
1. Risk factors and pattern of metastatic recurrence after endoscopic resection with additional treatment for esophageal cancer.
Tanaka I; Hatta W; Koike T; Takahashi S; Shimada T; Hikichi T; Toya Y; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Tatsuta T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Ohira T; Nakamura J; Nakamura T; Nakaya N; Iijima K; Matsumoto T; Fukuda S; Masamune A; Hirasawa D
Dis Esophagus; 2024 Jun; ():. PubMed ID: 38869095
[TBL] [Abstract][Full Text] [Related]
2. Risk of metastatic recurrence after endoscopic resection for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa: a multicenter retrospective study.
Hatta W; Koike T; Takahashi S; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Matsumoto T; Nakamura T; Nakaya N; Iijima K; Fukuda S; Masamune A;
J Gastroenterol; 2021 Jul; 56(7):620-632. PubMed ID: 33881632
[TBL] [Abstract][Full Text] [Related]
3. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment.
Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J
Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
Tsou YK; Lee CH; Le PH; Chen BH
Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma.
Kadota T; Sato D; Inaba A; Nishihara K; Takashima K; Nakajo K; Yukami H; Mishima S; Sawada K; Kotani D; Fujiwara H; Nakamura M; Hojo H; Yoda Y; Kojima T; Fujita T; Yano T
Esophagus; 2022 Jan; 19(1):153-162. PubMed ID: 34420139
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
Cho H; Abe S; Nonaka S; Suzuki H; Yoshinaga S; Okuma K; Yamamoto S; Daiko H; Kato K; Sekine S; Boku N; Saito Y
Dis Esophagus; 2024 Apr; 37(5):. PubMed ID: 38266034
[TBL] [Abstract][Full Text] [Related]
8. Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: A Comparison of Outcomes between Esophagectomy and Chemoradiotherapy.
Kanie Y; Okamura A; Asari T; Maruyama S; Sakamoto K; Fujiwara D; Kanamori J; Imamura Y; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(13):8428-8435. PubMed ID: 34085140
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcome of Additional Esophagectomy After Endoscopic Treatment for Superficial Esophageal Cancer.
Miyata H; Sugimura K; Kanemura T; Takeoka T; Yamamoto M; Shinno N; Hara H; Omori T; Yamamoto S; Ishihara R; Wada H; Takahashi H; Nishimura J; Matsuda C; Yasui M; Yano M
Ann Surg Oncol; 2021 Nov; 28(12):7230-7239. PubMed ID: 33959832
[TBL] [Abstract][Full Text] [Related]
10. Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?
Hombu T; Yano T; Hatogai K; Kojima T; Kadota T; Onozawa M; Yoda Y; Hori K; Oono Y; Ikematsu H; Fujii S
Dig Endosc; 2018 May; 30(3):338-346. PubMed ID: 29106753
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognosis after endoscopic resection of T1a-MM/T1b-SM1 esophageal squamous cell carcinoma.
Ohki D; Tsuji Y; Shinozaki T; Sakaguchi Y; Mizutani H; Nagao S; Miura Y; Fukagawa K; Tamura N; Yakabi S; Yamamichi N; Fujishiro M
Medicine (Baltimore); 2022 Dec; 101(49):e32115. PubMed ID: 36626416
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma.
Emi M; Hmai Y; Yoshikawa T; Hirohata R; Osawa M; Okada M; Murakami Y; Nishibuchi I
Anticancer Res; 2022 May; 42(5):2791-2795. PubMed ID: 35489771
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
Takahashi S; Hatta W; Watanabe K; Koike T; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Nakamura T; Nakaya N; Matsumoto T; Fukuda S; Masamune A; Iijima K
Dig Dis Sci; 2023 May; 68(5):2050-2060. PubMed ID: 36445654
[TBL] [Abstract][Full Text] [Related]
15. Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection.
Saeki H; Watanabe M; Mine S; Shigaki H; Oya S; Ishiyama A; Tsuchida T; Fujisaki J; Baba H; Maehara Y; Sano T
J Gastroenterol; 2015 Apr; 50(4):406-13. PubMed ID: 25084980
[TBL] [Abstract][Full Text] [Related]
16. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy.
Sun ZG; Wang Z; Liu XY; Liu FY
World J Surg; 2011 Jan; 35(1):70-7. PubMed ID: 21046381
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Superficial Esophageal Cancer: An Update].
Shin CM
Korean J Gastroenterol; 2021 Dec; 78(6):313-319. PubMed ID: 34955507
[TBL] [Abstract][Full Text] [Related]
19. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma.
Saunders JH; Al-Zubaidi S; Waller RC; Ortiz-Fernandez-Sordo J; Parsons SL; Ragunath K; Kaye PV;
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32090253
[TBL] [Abstract][Full Text] [Related]
20. cT1N0M0 Esophageal Squamous Cell Carcinoma Invades the Muscularis Mucosa or Submucosa: Comparison of the Results of Endoscopic Submucosal Dissection and Esophagectomy.
Wang CY; Chen BH; Lee CH; Le PH; Tsou YK; Lin CH
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
